REGN
Regeneron Pharmaceuticals
Health Care
Biotechnology
Tarrytown, New York
Last filing: Feb 4, 2026 (FY2025)
Balance Sheet 13 Accounts • 5 Years
| Account | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| BS_Assets_Cash | $0 | $2.5B | $2.7B | $3.1B | $2.9B |
| BS_Assets_AcctsReceivable | $0 | $6.2B | $5.7B | $5.3B | $6.0B |
| BS_Assets_Inventory | $0 | $3.1B | $2.6B | $2.4B | $2.0B |
| BS_Assets_PPE | $0 | $4.6B | $4.1B | $3.8B | $3.5B |
| BS_Assets_IntangibleAssets | $0 | $1.1B | $1.0B | $915.5M | $0 |
| BS_Assets_OtherNoncurrent | $0 | $1.1B | $444.1M | $336.4M | $222.8M |
| BS_Liab_AccruedLiab | $0 | $571.1M | $666.7M | $637.5M | $383.9M |
| BS_Liab_OtherCurrent | $0 | $213.2M | $0 | $0 | $326.3M |
| BS_Liab_LongTermDebt | $0 | $2.0B | $2.0B | $2.0B | $2.0B |
| BS_Liab_OtherNoncurrent | $0 | $1.6B | $854.1M | $638.0M | $680.2M |
| BS_Equity_PreferredStock | $0 | $0 | $0 | $0 | $0 |
| BS_Equity_CommonStock | $0 | $0 | $0 | $0 | $0 |
| BS_Equity_TreasuryStock | $0 | $15.2B | $12.6B | $10.4B | $8.3B |